Inclusion complexes of Sulconazole with β-cyclodextrin and hydroxypropyl β-cyclodextrin: Characterization in aqueous solution and in solid state

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 61, Issue 1-2, 2008, Pages 41-51

  Spulber, Mariana ^a   Pinteala, Mariana ^a   Harbagiu, Valeria ^a   Simionescu, Bogdan C ^a  

^a PETRU PONI INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 43949084749     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-007-9391-3     Document Type: Article

References (13)

1. 1. A.R. Hedges 1998 Industrial applications of cyclodextrins Chem. Rev. 98 2035 2044 10.1021/cr970014w 1:CAS:528:DyaK1cXksV2iurw%3D Hedges, A.R.: Industrial applications of cyclodextrins. Chem. Rev. 98, 2035–2044 (1998)
2. 2. T. Loftsson M.E. Brewster 1996 Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization J. Pharm. Sci. 85 1017 1025 10.1021/js950534b 1:CAS:528:DyaK28XlsFSrsr4%3D Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017–1025 (1996)
3. 3. H. Vanden Bossche P. Marichal J. Gorrens D. Bellens H. Moereels P.A.J. Janssen 1990 Mutations in cytochrome P450-dependent 14-demethylase result in decreased affinity for azole antifungals Biochem. Soc. Trans. 18 124 126 Vanden Bossche, H., Marichal, P., Gorrens, J., Bellens, D., Moereels, H., Janssen, P.A.J.: Mutations in cytochrome P450-dependent 14-demethylase result in decreased affinity for azole antifungals. Biochem. Soc. Trans. 18, 124–126 (1990)
4. 4. D.J. Nosanchuk 2006 Current status and future of antifungal therapy for systemic mycoses Recent Patents Anti-Infect. Drug Disc. 1 36 41 Nosanchuk, D.J.: Current status and future of antifungal therapy for systemic mycoses. Recent Patents Anti-Infect. Drug Disc. 1, 36–41 (2006)
5. 5. C.A. Hitchcock Barret 1987 The lipid composition and permeability to azole of an azole and poliene-resistant mutant of Candida albicans J. Med. Vet. Micol. 25 29 37 10.1080/02681218780000041 1:CAS:528:DyaL2sXkt1Slsrs%3D Hitchcock, C.A., Barret Bee, K.J., Rusell, N.J.: The lipid composition and permeability to azole of an azole and poliene-resistant mutant of Candida albicans. J. Med. Vet. Micol. 25, 29–37 (1987)
6. 6. Stoescu, V.: Bazele farmacologice ale practicii medicale. Editura Medicala-Bucuresti, ed. a 7-a, rev. si compl (2001)
7. 7. T. Higuchi K.A. Connors 1965 Phase-solubility techniques Adva. Anal. Chem. Instr. 4 212 217 Higuchi, T., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Instr. 4, 212–217 (1965)
8. 8. Manca 2005 Diclofenac-β-Cyclodextrin Binary Systems: physicochemical characterization and in vitro dissolution and diffusion studies AAPS PharmSciTech. 6 3 464 472 10.1208/pt060358 Manca, M.L., Zaru, M., Ennas, G., Valenti, D., Sinico, C., Loy, G., Fadda, A.M.: Diclofenac-β-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies. AAPS PharmSciTech. 6 (3), 464–472 (2005)
9. 9. Mukne, A.P., Nagarsenker, M.S.: Triamterene-β-cyclodextrin systems: preparation, characterization and in vivo evaluation. AAPS PharmSciTech. 5 (1), 1–9 (2004)
10. 10. Piel, G., Dive, G., Ervard, B., Van Hees, T., Henry de Hassonville, S., Delattre, L.: Molecular modeling study of β-and γ-cyclodextrin complexes with miconazole. Eur. J. Pharm. Sci. 13, 271–279 (2001)
11. 11. Redenti, E., Fronza, G., Spisni, A.: Nuclear overhauser effect, a powerful tool for the investigation of the geometry in solution of different inclusion complexes with β-cyclodextrin. Minutes Int. Symp. Cyclodextrins 220–225 (1992)
12. 12. N. Mulinacci F. Melani F.F. Vincieri G. Mazzi A. Romani 1995 1H-NMR NOEand molecular modelling to characterize thymol and carvacol (-cyclodextrin complexes Int. J. Pharm. 128 81 88 10.1016/0378-5173(95)04224-5 Mulinacci, N., Melani, F., Vincieri, F.F., Mazzi, G., Romani, A.: 1H-NMR NOE and molecular modelling to characterize thymol and carvacol (-cyclodextrin complexes. Int. J. Pharm. 128, 81–88 (1995)
13. 13. N. Morin 1999 Formation of two particular structures between (-cyclodextrin and bifazole: (-CD-bifonazole (where 2 < i < 3) J. Chem. Soc. Perkin. Trans. 2 2647 2651 Morin, N. et al.: Formation of two particular structures between (-cyclodextrin and bifazole: (-CD-bifonazole (where 2 < i < 3). J. Chem. Soc. Perkin. Trans. 2, 2647–2651 (1999)